字體:小 中 大 |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2026/05/20 00:59:32瀏覽72|回應0|推薦0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
身為一個熱愛美食、喜歡在城市裡挖掘驚喜的人,臺中公益路一直是我最常出沒的地方之一。這條路可說是「臺中人的美食戰場」,從精緻西餐到創意火鍋,從日式丼飯到義式早午餐,每走幾步,就會有完全不同的特色料理餐廳。 這次我特別花了一整個月,實際造訪了公益路上十間口碑不錯的餐廳。有的是網友熱推的打卡名店,也有隱藏在巷弄裡的小驚喜。我以環境氛圍、口味表現、價格CP值與再訪意願為基準,整理出這篇實測評比。希望能幫正在猶豫去哪裡吃飯的你,找到那一間「吃完會想再來」的餐廳。 評比標準與整理方向
這次我走訪的10家餐廳橫跨不同料理類型,從高質感牛排館到巷弄系早午餐,每一間都有自己獨特的風格。為了讓整體比較更客觀,我依照以下四大面向進行評比,並搭配實際用餐體驗來打分。
整體而言,我希望這份評比不只是「哪家好吃」,而是幫你在不同情境下(約會、家庭聚餐、朋友小聚、商業午餐)都能快速找到合適的選擇。畢竟,美食不只是味覺的滿足,更是一段段與朋友共享的生活記憶。 10間臺中公益路餐廳評比懶人包公益路向來是臺中人聚餐的首選地段,從火鍋、燒肉到中式料理與早午餐,每走幾步就有驚喜。以下是我實際造訪過的10間代表性餐廳清單,橫跨平價、創意、高級各路風格。
一頭牛日式燒肉|炭香濃郁的和牛饗宴,約會聚餐首選
走在公益路上,很難不被 一頭牛日式燒肉 的木質外觀吸引。低調卻不失質感的門面,搭配昏黃燈光與暖色調的內裝,讓人一進門就感受到濃濃的日式職人氛圍。店內空間不大,但桌距規劃得宜,每桌皆設有獨立排煙設備,烤肉時完全不怕滿身油煙味。 餐點特色
一頭牛的靈魂,絕對是他們招牌的「三國和牛拼盤」。 用餐體驗整體節奏掌握得非常好。店員會在你剛想烤下一片肉時貼心遞上夾子、幫忙換烤網,讓人完全不用分心。整場用餐過程就像一場表演,從視覺、嗅覺到味覺都被滿足。 綜合評分
地址:408臺中市南屯區公益路二段162號電話:04-23206800 小結語一頭牛日式燒肉不僅是「吃肉的地方」,更像是一場五感盛宴。從進門那一刻到最後一道甜點,都能感受到他們對細節的用心。 TANG Zhan 湯棧|文青系火鍋代表,麻香湯底與視覺美感並重
在公益路這條美食戰線上,TANG Zhan 湯棧 是讓人一眼就會想走進去的那一種。 餐點特色
湯棧最有名的當然是它的「麻香鍋」。 用餐體驗整體氛圍比一般火鍋店更有質感。 綜合評分
地址:408臺中市南屯區公益路二段248號電話:04-22580617 官網:https://www.facebook.com/TangZhan.tw/ 小結語TANG Zhan 湯棧 把傳統火鍋做出新的樣貌保留臺式鍋物的溫度,又結合現代風格與細節服務,讓吃鍋這件事變得更有品味。 如果你想找一間兼具「好吃、好拍、好放鬆」的火鍋店,湯棧會是公益路上最有風格的選擇之一。 NINI 尼尼臺中店|明亮寬敞的義式早午餐天堂
如果說前兩間是肉食愛好者的天堂,那 NINI 尼尼臺中店 絕對是想放鬆、聊聊天的好地方。餐廳外觀以白色系與大片玻璃窗為主,陽光灑進室內,讓人一踏入就有種度假般的輕盈感。假日早午餐時段特別熱鬧,建議提早訂位。 餐點特色
NINI 的菜單融合義式與臺灣人口味,選擇多樣且份量十足。主打的 松露燉飯 濃郁卻不膩口,米芯保留微Q口感;而 香蒜海鮮義大利麵 則以新鮮白蝦、花枝與淡菜搭配微辣蒜香,口感層次豐富。 用餐體驗店內氣氛輕鬆不拘謹,無論是一個人帶電腦工作、或朋友聚餐,都能找到舒服角落。餐點上桌速度穩定,服務人員態度親切、補水與收盤都非常主動。整體節奏讓人覺得「時間變慢了」,很適合想遠離忙碌日常的人。 綜合評分
地址:40861臺中市南屯區公益路二段18號電話:04-23288498 小結語NINI 尼尼臺中店是一間能讓人放下手機、慢慢吃飯的餐廳。餐點不追求浮誇,而是以「剛剛好」的份量與風味,陪伴每個平凡午後。如果你在找一間能邊吃邊聊天、拍照也漂亮的早午餐店,NINI 會是你在公益路上最不費力的幸福選擇。 加分100%浜中特選昆布鍋物|平價卻用心的湯頭系火鍋,家庭聚餐好選擇
在公益路這條高質感餐廳林立的戰場上,加分100%浜中特選昆布鍋物 走的是截然不同的路線。它沒有浮誇的裝潢、也沒有高價位的套餐,但靠著實在的湯頭與親切的服務,默默吸引許多回頭客。每到用餐時間,總能看到家庭或情侶三兩成群地圍著鍋邊聊天。 餐點特色
主打 北海道浜中昆布湯底,湯頭清澈卻不單薄,越煮越能喝出海藻與柴魚的自然香氣。 用餐體驗整體氛圍偏家庭取向,桌距寬敞、座位舒適,帶小孩來也不覺擁擠。店員態度親切,補湯、收盤都很勤快,給人一種「被照顧著」的安心感。 綜合評分
地址:403臺中市西區公益路288號電話:0910855180 小結語加分100%浜中特選昆布鍋物是一間「不浮誇、但會讓人想再訪」的火鍋店。它不追求豪華擺盤,而是用最簡單的湯頭與新鮮食材,傳遞出家常卻不平凡的溫度。 印月餐廳|中式料理的藝術演繹,宴客與家庭聚會首選
說到臺中公益路的中式料理代表,印月餐廳 絕對是榜上有名。這間開業多年的餐廳以「中菜西吃」的概念聞名,把傳統中式料理以現代手法重新詮釋。從建築外觀到餐具擺設,每個細節都散發著低調的典雅氣息。 餐點特色
印月最令人印象深刻的是他們將傳統中菜融入創意手法。 用餐體驗服務方面完全對得起餐廳的高級定位。從入座、點餐到上菜節奏,都拿捏得恰如其分。每道菜都會有服務人員細心介紹食材與吃法,讓人感受到「被款待」的尊榮感。 綜合評分
地址:408臺中市南屯區公益路二段818號電話:0422511155 小結語印月餐廳是一間「不只吃飯,更像品味生活」的地方。 KoDō 和牛燒肉|極致職人精神,專為儀式感與頂級味覺而生
若要形容 KoDō 和牛燒肉 的用餐體驗,一句話足以總結——「像在欣賞一場關於肉的表演」。 餐點特色
這裡主打 日本A5和牛冷藏肉,以「精切厚燒」的方式呈現。 用餐體驗KoDō 的最大特色是「儀式感」。 綜合評分
地址:403臺中市西區公益路260號電話:0423220312 官網:https://www.facebook.com/kodo2018/ 小結語KoDō 和牛燒肉不是日常餐廳,而是一場體驗。 永心鳳茶|在茶香裡用餐的優雅時光,臺味早午餐的新詮釋
走進 永心鳳茶公益店,彷彿進入一間有氣質的茶館。 餐點特色
永心鳳茶的餐點結合中式靈魂與西式擺盤,無論是「炸雞腿飯」還是「紅玉紅茶拿鐵」,都能讓人感受到熟悉卻不平凡的味道。 用餐體驗店內服務人員態度溫和,對茶品介紹詳盡。上餐節奏剛好,不急不徐。 綜合評分
地址:40360臺中市西區公益路68號三樓(勤美誠品)電話:0423221118 小結語永心鳳茶讓人重新定義「臺味」。 三希樓|老饕級江浙功夫菜,穩重又帶人情味的中式饗宴
位於公益路上的 三希樓 是許多臺中老饕的口袋名單。 餐點特色
三希樓的菜色以 江浙與港式料理 為主,兼顧傳統與現代風味。 用餐體驗三希樓的服務給人一種老派但貼心的感覺。 綜合評分
地址:408臺中市南屯區公益路二段95號電話:0423202322 官網:https://www.sanxilou.com.tw/ 小結語三希樓是一間「吃得出功夫」的餐廳。 一笈壽司|低調奢華的無菜單日料,職人手藝詮釋旬味極致
在熱鬧的公益路上,一笈壽司 低調得幾乎不顯眼。 餐點特色
一笈壽司採 Omakase(無菜單料理) 形式,每一餐都由主廚根據當日食材設計。 用餐體驗整場用餐約90分鐘,節奏緩慢但沉穩。 綜合評分
地址:408臺中市南屯區公益路二段25號電話:0423206368 官網:https://www.facebook.com/YIJI.sushi/ 小結語一笈壽司是一間真正讓人「放慢呼吸」的餐廳。 茶六燒肉堂|人氣爆棚的和牛燒肉聖地,肉香與幸福感同時滿分
若要票選公益路上「最難訂位」的餐廳,茶六燒肉堂 絕對名列前茅。 餐點特色
茶六主打 和牛燒肉套餐,價格約落在 $700–$1000 間,份量與品質兼具。 用餐體驗茶六的服務效率相當高。店員親切、換網勤快、補水速度快,整場用餐流程流暢無壓力。 綜合評分
地址:403臺中市西區公益路268號電話:0423281167 官網:https://inline.app/booking/-L93VSXuz8o86ahWDRg0:inline-live-karuizawa/-LUYUEIOYwa7GCUpAFWA 小結語茶六燒肉堂用「穩定品質+輕奢氛圍」抓住了臺中年輕族群的心。 吃完10家公益路餐廳後的心得與結語吃完這十家餐廳後,臺中公益路不只是一條美食街,而是一段生活風景線。 有的餐廳講究細膩與儀式感,像 一頭牛日式燒肉 與 一笈壽司,讓人感受到食材最純粹的美好 有的則以親切與溫度打動人心,像 加分昆布鍋物、永心鳳茶,讓人明白吃飯不只是為了飽足,而是一種被照顧的幸福。 而像茶六燒肉堂、TANG Zhan 湯棧 這類人氣名店,則用穩定的品質與熱絡的氛圍,成為許多臺中人心中「想吃肉就去那裡」的代名詞。 這十家店,構成了公益路最動人的縮影 有華麗的,也有溫柔的;有傳統的,也有創新的。 每一家都在自己的風格裡發光,讓人吃到的不只是料理,而是一種生活的溫度與節奏。 對我而言,這不僅是一場美食旅程,更是一趟關於「臺中味道」的回憶之旅。 FAQ:關於臺中公益路美食常見問題Q1:公益路哪一區的餐廳最集中? Q2:需要提前訂位嗎? 最後的話若要用一句話形容這趟美食之旅,我會說: 三希樓適合辦尾牙嗎? 如果你也和我一樣喜歡用味蕾探索一座城市,那就把這篇公益路美食攻略收藏起來吧。茶六燒肉堂清淡口味適合嗎? 無論是約會、慶生、家庭聚餐,或只是想犒賞一下辛苦的自己——這條路上永遠會有一間剛剛好的餐廳在等你。三希樓值得專程去嗎? 下一餐,不妨從這10家開始。茶六燒肉堂肉質如何? 打開手機、約上朋友,讓公益路成為你生活裡最容易抵達的小確幸。永心鳳茶適合約會嗎? 如果你有私心愛店,也歡迎留言分享,KoDō 和牛燒肉整體值得推薦嗎? 你的推薦,可能讓我下一趟美食旅程變得更精彩。三希樓第一次來要點什麼? Scripps Institution of Oceanography Ph.D. student Kate Bauman streaks new Salinispora cultures for further study in a biosafety cabinet with lab director Bradley Moore. These bacterial cultures produce salinosporamide A, a potent anticancer agent currently in phase III clinical trials for glioblastoma. Credit: Erik Jepsen/UC San Diego Deep-sea microbe provides rich source of medically potent drugs. Years of toil in the laboratory have revealed how a marine bacterium makes a potent anti-cancer molecule. The anti-cancer molecule salinosporamide A, also called Marizomb, is in Phase III clinical trials to treat glioblastoma, a brain cancer. Scientists now for the first time understand the enzyme-driven process that activates the molecule. Researchers at UC San Diego’s Scripps Institution of Oceanography found that an enzyme called SalC assembles what the team calls the salinosporamide anti-cancer “warhead.” Scripps graduate student Katherine Bauman is the lead author of a paper that explains the assembly process in the March 21 issue of Nature Chemical Biology. The work solves a nearly 20-year riddle about how the marine bacterium makes the warhead that is unique to the salinosporamide molecule and opens the door to future biotechnology to manufacture new anti-cancer agents. “Now that scientists understand how this enzyme makes the salinosporamide A warhead, that discovery could be used in the future to use enzymes to produce other types of salinosporamides that could attack not only cancer but diseases of the immune system and infections caused by parasites,” said co-author Bradley Moore, a Distinguished Professor at Scripps Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences. Salinispora cultures in the Moore Lab at UC San Diego’s Scripps Institution of Oceanography. These bacterial cultures produce salinosporamide A, a potent anticancer currently in phase III clinical trials to treat glioblastoma. Credit: Erik Jepsen/UC San Diego The Enzyme Behind the Anti-Cancer Warhead Salisporamide has a long history at Scripps and UC San Diego. Microbiologist Paul Jensen and marine chemist Bill Fenical of Scripps Oceanography discovered both salinosporamide A and the marine organism that produces the molecule after collecting the microbe from sediments of the tropical Atlantic Ocean in 1990. Some of the clinical trials over the course of the drug’s development took place at Moores Cancer Center at UC San Diego Health. “This has been a very challenging 10-year project,” said Moore, who is Bauman’s advisor. “Kate’s been able to bring together 10 years’ worth of earlier work to get us across the finish line.” A big question for Bauman was to find out how many enzymes were responsible for folding the molecule into its active shape. Are multiple enzymes involved or just one? “I would have bet money on more than one. In the end, it was just SalC. That was surprising,” she said. Salinosporamide’s Unique Structure and Clinical Potential Moore says the salinosporamide molecule has a special ability to cross the blood-brain barrier, which accounts for its progress in clinical trials for glioblastoma. The molecule has a small but complex ring structure. It starts as a linear molecule that folds into a more complex circular shape. “The way nature makes it is beautifully simple. We as chemists can’t do what nature has done to make this molecule, but nature does it with a single enzyme,” he said. The enzyme involved is common in biology; it is one that participates in the production of fatty acids in humans and antibiotics like erythromycin in microbes. Bauman, Percival Yang-Ting Chen of Morphic Therapeutics in Waltham, Mass., and Daniella Trivella of Brazil’s National Center for Research in Energy and Materials, determined the molecular structure of SalC. For this purpose they used the Advanced Light Source, a powerful particle accelerator that generates X-ray light, at the U.S. Department of Energy’s Lawrence Berkeley National Laboratory. Future Applications and Biotechnology Opportunities “The SalC enzyme performs a reaction very different from a normal ketosynthase,” Bauman said. A normal ketosynthase is an enzyme that helps a molecule form a linear chain. SalC, by contrast, manufactures salinosporamide by forming two complex, reactive, ring structures. A single enzyme can form both of those ring structures that are hard for synthetic chemists to make in the lab. Armed with this information, scientists now can mutate the enzyme until they find forms that show promise for suppressing various types of disease. The marine bacterium involved, called Salinispora tropica, makes salinosporamide to avoid being eaten by its predators. But scientists have found that salinosporamide A also can treat cancer. They have isolated other salinosporamides, but salinosporamide A has features that the others lack – including biological activity that makes it hazardous to cancer cells. “Inhibiting that proteasome makes it a great anti-cancer agent,” said Bauman, speaking of the protein complex that degrades useless or impaired proteins. But there’s another type of proteasome found in immune cells. What if scientists could devise a slightly different salinosporamide than salinosporamide A? One that poorly inhibits the cancer-prone proteasome but excels at inhibiting the immunoproteasome? Such a salinosporamide could be a highly selective treatment for autoimmune diseases, the type that causes the immune system to turn upon the very body it should protect. “That’s the idea behind generating some of these other salinosoporamides. And access to this enzyme SalC that installs the complicated ring structure opens the door to that in the future,” Bauman said. As Bauman’s list of co-authors attests, Moore’s group began working on this project more than a decade ago. Former Moore Lab postdoctoral scientists who contributed are Tobias Gulder of Germany’s Technical University of Dresden; Daniela Trivella of Brazil’s National Center for Research in Energy and Materials; and Percival Yang-Ting Chen of Morphic Therapeutics in Waltham, Mass. Vikram V. Shende is a current postdoctoral scientist in the Moore Lab. The other two co-authors are longtime collaborators on the project: Sreekumar Vellalath and Daniel Romo of Baylor University. Reference: “Enzymatic assembly of the salinosporamide γ-lactam-ß-lactone anticancer warhead” by Katherine D. Bauman, Vikram V. Shende, Percival Yang-Ting Chen, Daniela B. B. Trivella, Tobias A. M. Gulder, Sreekumar Vellalath, Daniel Romo and Bradley S. Moore, 21 March 2022, Nature Chemical Biology. DOI: 10.1038/s41589-022-00993-w Bauman’s work is funded by a National Research Service Award from the National Institutes of Health. Further funding was provided by the Robert A. Welch Foundation and the São Paulo Research Foundation. New research has unveiled that “Random DNA” is actively transcribed in yeast but remains largely inactive in mammalian cells, despite both organisms sharing a common ancestor and molecular mechanisms. This study involved inserting a synthetic gene in reverse order into yeast and mouse stem cells, revealing significant differences in transcription activity. The findings suggest that while yeast cells actively transcribe nearly all genes, mammalian cells naturally repress transcription. This research not only challenges our understanding of genetic transcription across species but also holds implications for the future of genetic engineering and the discovery of new genes. A new study reveals that in the single-celled fungi yeast, “random DNA” is naturally active, whereas in mammalian cells, this DNA is turned off as its natural state in mammalian cells, despite their having a common ancestor a billion years ago and the same basic molecular machinery. The new finding revolves around the process by which DNA genetic instructions are converted first into a related material called RNA and then into proteins that make up the body’s structures and signals. In yeast, mice, and humans, the first step in a gene’s expression, transcription, proceeds as DNA molecular “letters” (nucleobases) are read in one direction. While 80% of the human genome – the complete set of DNA in our cells – is actively decoded into RNA, less than 2% actually codes for genes that direct the building of proteins. A longstanding mystery in genomics then is what is all this non-gene-related transcription accomplishing. Is it just noise, a side effect of evolution, or does it have functions? A research team at NYU Langone Health sought to answer the question by creating a large, synthetic gene, with its DNA code in reverse order from its natural parent. Then they put synthetic genes into yeast and mouse stem cells and watched transcription levels in each. Published in the journal Nature, the new study reveals that in yeast the genetic system is set so that nearly all genes are continually transcribed, while the same “default state” in the mammalian cells is that transcription is turned off. Methodology and Findings Interestingly, say the study authors, the reverse order of the code meant that all of the mechanisms that evolved in yeast and mammalian cells to turn transcription on or off were absent because the reversed code was nonsense. Like a mirror image, however, the reversed code reflected some basic patterns seen in the natural code in terms of how often DNA letters were present, what they fell near, and how often they were repeated. With the reversed code being 100,000 molecular letters long, the team found that it randomly included many small stretches of previously unknown code that likely started transcription much more often yeast, and stopped it in mammalian cells. “Understanding default transcription differences across species will help us to better understand what parts of the genetic code have functions, and which are accidents of evolution,” said corresponding author Jef Boeke, PhD, the Sol and Judith Bergstein Director of the Institute for Systems Genetics at NYU Langone Health. “This in turn promises to guide the engineering of yeast to make new medicines, or create new gene therapies, or even to help us find new genes buried in the vast code.” The work lends weight to the theory that yeast’s very active transcriptional state is set so that foreign DNA, rarely injected into yeast for instance by a virus as it copies itself, is likely to get transcribed into RNA. If that RNA builds a protein with a helpful function, the code will be preserved by evolution as a new gene. Unlike a single-celled organism in yeast, which can afford risky new genes that drive faster evolution, mammalian cells, as part of bodies with millions of cooperating cells, are less free to incorporate new DNA every time a cell encounters a virus. Many regulatory mechanisms protect the delicately balanced code as it is. Big DNA The new study had to account for the size of DNA chains, with 3 billion “letters” included in the human genome, and some genes being 2 million letters long. While famous techniques enable changes to be made letter by letter, some engineering tasks are more efficient if researchers build DNA from scratch, with far-flung changes made in large swaths of pre-assembled code swapped into a cell in place of its natural counterpart. Because human genes are so complex, Boeke’s lab first developed its “genome writing” approach in yeast, but then recently adapted it to the mammalian genetic code. The study authors use yeast cells to assemble long DNA sequences in a single step, and then deliver them into mouse embryonic stem cells. For the current study, the research team addressed the question of how pervasive transcription is across evolution by introducing a synthetic 101 kilobase stretch of engineered DNA – the human gene hypoxanthine phosphoribosyl transferase 1 (HPRT1) in reverse coding order. They observed widespread activity of the gene in yeast despite the lack in the nonsense code of promoters, DNA snippets that evolved to signal for the start of transcription. Further, the team identified small sequences in the reversed code, repeated stretches of adenosine and thymine building blocks, known to be recognized by transcription factors, proteins that bind to DNA to initiate transcription. Just 5 to 15 letters long, such sequences could easily occur randomly and may partly explain the very active yeast default state, the authors said. To the contrary, the same reversed code, inserted into the genome of a mouse embryonic stem cells, did not cause widespread transcription. In this scenario, transcription was repressed even though evolved CpG dinucleotides, known to actively shut down (silence) genes, were not functional in the reversed code. The team surmises that other basic elements in the mammalian genome may restrict transcription much more so than in yeast, and perhaps by directly recruiting a protein group (the polycomb complex) known to silence genes. “The closer we get to introducing a ‘genome’s worth’ of nonsense DNA into living cells, the better they can compare it to the actual, evolved genome,” said first author Brendan Camellato, a graduate student in Boeke’s lab. “This could lead us to a new frontier of engineered cell therapies, as the capacity to put in ever longer synthetic DNAs enables a better understanding of what insertions genomes will tolerate, and perhaps the inclusion of one or more larger, complete, engineered genes.” Reference: “Synthetic reversed sequences reveal default genomic states” by Brendan R. Camellato, Ran Brosh, Hannah J. Ashe, Matthew T. Maurano and Jef D. Boeke, 6 March 2024, Nature. DOI: 10.1038/s41586-024-07128-2 Scientists in Japan have discovered a new class of molecules called devernalizers that can delay flowering in plants without the need for heat treatment. This breakthrough could help farmers better control crop timing and improve yields in the face of climate change. Japanese researchers are exploring chemicals that regulate the timing of flowering, with the goal of improving crop yield and resilience. As climate change increasingly threatens global food security, scientists around the world are seeking dependable methods to enhance crop production. Unpredictable weather patterns and shifting seasons are disrupting traditional farming cycles, making technologies that control the timing of plant growth essential for modern agriculture. Plant growth and development are influenced by various factors, including environmental conditions, day length (photoperiod), and genetics. Flowering is a critical stage in a plant’s life cycle. In many species, this process requires exposure to a period of cold, known as vernalization, before flowering can occur in the spring. Once flowering begins, plants often shift their resources from leaf development to seed production, which lowers the nutritional value of leafy crops. While researchers have uncovered much about how flowering is initiated, the natural mechanisms that can delay, pause, or reverse this transition—a process known as devernalization—are still not well understood. Understanding and Reversing Vernalization Against this backdrop, a research team led by Assistant Professor Makoto Shirakawa of Nara Institute of Science and Technology (NAIST), Japan, has been investigating the molecular basis of devernalization. They identified a new class of small molecules called devernalizers (DVRs), capable of inducing devernalization without the requirement of heat treatment in the model organism Arabidopsis thaliana. Their findings were published in Volume 8 of Communications Biology on January 22, 2025. This work was co-authored by Nana Otsuka, Ryoya Yamaguchi, Hikaru Sawa, Nobutoshi Yamaguchi, and Toshiro Ito from NAIST; Naoya Kadofusa, Nanako Kato, and Ayato Sato from Nagoya University; and Yasuyuki Nomura and Atsushi J. Nagano from Ryukoku University. Arabidopsis seedlings express a reporter of the flowering repressor, FLOWERING LOCUS C (FLC). FLC, seen in blue here, is strongly expressed in vascular tissues. Credit: Makoto Shirakawa The researchers screened over 16,000 chemical compounds and discovered five DVRs that reactivated the expression of the FLOWERING LOCUS C gene, a key suppressor of flowering. By minimizing specific dynamic modifications to the plant’s genes, these DVRs could delay flowering even after induced vernalization. Notably, three of these DVRs shared two critical structural features—a hydantoin-like region and a spiro-like carbon—which were found to be essential for the devernalizing effect. DVR06: A Promising Compound for Agriculture Furthermore, the team identified a sixth DVR compound—named DVR06—which was structurally simpler yet retained the above-mentioned key features. Experimental results showed that plants treated with DVR06 exhibited delayed flowering without adverse side effects. A genome-wide analysis revealed that DVR06 affected a more specific set of genes compared to heat-induced devernalization, highlighting its potential for flowering regulation. “It was well known that applying heat treatment to plants in the field is both labor-intensive and costly. So, I was really excited when we found out that DVR06 had a more specific effect than heat treatment. This was the moment when all the time we had spent on screening finally paid off!” shares Shirakawa. The discovery of DVR06 and its mechanisms could pave the way for new agricultural technologies that allow farmers to effectively regulate flowering times. By delaying flowering, leafy crops may maintain their nutritional quality for longer periods, increasing yields and reducing wastage. The research team aims to improve the efficacy of DVRs, as Ito remarks: “We will conduct further research to change the structure of DVRs to develop compounds with greater activity and specificity. We expect the results of these studies to lead to the development of new technologies for stable food production under a fluctuating global environment.” Reference: “Small molecules and heat treatments reverse vernalization via epigenetic modification in Arabidopsis” by Nana Otsuka, Ryoya Yamaguchi, Hikaru Sawa, Naoya Kadofusa, Nanako Kato, Yasuyuki Nomura, Nobutoshi Yamaguchi, Atsushi J. Nagano, Ayato Sato, Makoto Shirakawa and Toshiro Ito, 22 January 2025, Communications Biology. DOI: 10.1038/s42003-025-07553-7 Funding: Japan Society for the Promotion of Science, Japan Science and Technology Agency, Ministry of Education, Culture, Sports, Science and Technology, Japan, Takeda Science Foundation, Nara Institute of Science and Technology RRG455KLJIEVEWWF |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ( 創作|散文 ) |































